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Introduction: Glossopharyngeal neuralgia is an uncommon, painful syndrome, characterized by paroxysms of pain
in the sensory distribution of the 9th cranial nerve. Idiopathic glossopharyngeal neuralgia may be due to
compression of the glossopharyngeal nerve by adjacent vessels, while secondary glossopharyngeal neuralgia is
associated with identifiable lesions affecting the glossopharyngeal nerve at different levels of its neuroanatomic
pathway. Glossopharyngeal neuralgia is rare in the general population, but is more common in patients with
multiple sclerosis.
Case presentation: A 56-year-old Caucasian woman with multiple sclerosis and migraine presented to our facility
with intermittent lancinating pain to the right of her throat, tongue, and the floor of her mouth that had been
occurring for the past year. The pain was intense, sharp, and stabbing, which lasted two to six seconds with
radiation to the right ear. Initially, the attacks were infrequent, however, they had become more intense and
frequent over time. Our patient reported weight loss, headache, painful swallowing, and the inability to maintain
sleep due to painful attacks. A neurological examination revealed a right-handed woman with trigger points in the
back of the tongue and throat on the right side. She also had dysphagia, hoarseness, and pain in the distribution of
the right glossopharyngeal nerve. Mild right hemiparesis, hyperreflexia, dysmetria, and an ataxic gait were present.
A magnetic resonance imaging scan of the brain was consistent with multiple sclerosis and magnetic resonance
angiography demonstrated a loop of the posterior inferior cerebellar artery compressing the right glossopharyngeal
nerve. She responded satisfactorily to carbamazepine. Microvascular decompression and Gamma KnifeW
radiosurgery were discussed in case of failure of the medical treatment; however, she declined these options.
Conclusions: Glossopharyngeal neuralgia in multiple sclerosis may occur due to vascular compressive lesions and it
should not be solely attributed to the underlying demyelinating process. Vascular compression of the
glossopharyngeal nerve could independently cause glossopharyngeal neuralgia in patients with multiple sclerosis,
and vascular imaging to exclude such a diagnosis is recommended.Introduction
Glossopharyngeal neuralgia (GPN) is a rare painful syn-
drome, which is characterized by paroxysms of pain in
the sensory distribution of the 9th cranial nerve. Idio-
pathic (essential) GPN is caused by compression of the
glossopharyngeal nerve by adjacent vessels; secondary
(symptomatic) GPN is associated with various lesions* Correspondence: aminag@lsuhsc.edu
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reproduction in any medium, provided the orthat affect the glossopharyngeal nerve at different levels
of its path, such as brainstem structures, cisternal
branches, jugular foramen, as well as its extracranial
divisions. The incidence of GPN is about 0.7 per 100,000
people in the general population [1]. Like trigeminal
neuralgia (TN), which occurs more often in patients
with multiple sclerosis (MS), GPN is also more common
in the MS population than in the general population.
However, only 0.5 per 1000 patients with MS develop
GPN [1]. Here, we present the case of a patient with MS
and GPN who also had vascular compression of theLtd. This is an Open Access article distributed under the terms of the Creative
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lar artery.Figure 1 Magnetic resonance imaging scans: fluid attenuated
inversion recovery (FLAIR) sequence, transverse plane. Shown
are demyelinating areas involving the periventricular areas of the
lateral ventricles, more prominent in the posterior. A similar
demyelination process is present in the white matter of the brain
sulci (medullary white matter).Case presentation
A 56-year-old right-handed Caucasian woman with
long-standing MS presented to our facility with intense,
intermittent pain in the right side of her tongue and
floor of her mouth, which was precipitated by speaking,
chewing, and swallowing. The episodic pain was intense,
sharp, and with a lancinating character, and lasted from
two to six seconds. She developed the pain one year
prior to her last visit and later on she also experienced
vocal hoarseness. The pain was localized to the posterior
part of her tongue and surrounding areas on her right
side. On certain occasions the pain radiated to her right
ear. The laryngeal pain had an episodic nature and be-
tween attacks our patient was free from pain. Initially
she had a few attacks of this pain per week, however, the
frequency and intensity of the pain gradually increased.
At the end of the year she noticed that her voice became
significantly hoarse and the attacks were triggered not
only by swallowing but also by speaking. She modified
and restricted her diet to only soft food and liquids, with
only temporary relief. During the last two weeks prior to
her visit the throat pain recurred regularly with eating
and speaking. She saw her primary care physician, who
prescribed hydrocodone with only partial relief.
She was diagnosed with MS and migraine 18 years
prior to case presentation. At the time of her new head
and neck pain she was on interferon-β1a 30 μg intra-
muscularly once weekly.
A neurological examination revealed a middle-aged
woman with stable vital signs and normal mental status.
She was oriented to all cognitive spheres with no apha-
sia, apraxia, or agnosia. During the assessment she was
in pain off and on, and pain was precipitated by speak-
ing. A cranial nerve examination revealed dysphagia,
vocal hoarseness, and pain in the distribution of the
right glossopharyngeal nerve (posterior third of the
tongue, floor of the mouth, and right side of the throat).
Her palate was symmetrically moving upon phonation
and her gag reflex was present. Our patient had difficulty
with differentiating basic tastes, particularly salty tastes
on the right side of the posterior of her tongue during
the painful attacks. Normal sensation in the distribution
of cranial nerve IX was present. She was also right hemi-
paretic with a wide-based stance and ataxic gait. Her
deep tendon reflexes were depressed and her plantar
responses were flexor.
A speech pathologist evaluated our patient and could
not determine any sign of aspiration; however, a soft
mechanical diet with chopped meat, feeding at 90
degrees, with small boluses and maintained in the sittingposition with head elevated to avoid and aspiration for
30 minutes.
A magnetic resonance imaging (MRI) scan of the brain
with and without contrast and a magnetic resonance
angiogram of the head and neck vessels were performed.
On axial fluid attenuated inversion recovery (FLAIR)
MRI scans of the brain, multiple hyperintense lesions
were present in the periventricular areas (Figure 1), me-
dulla, left side of pons, right middle cerebellar peduncle,
the left cerebellar dentate nucleus, and in the prerubral
area of the midbrain. On T1-weighted images a number
of hypointense lesions consistent with T1-weighted
black holes were present. No post-contrast T1-weighted
enhancing lesions were present. Corpus callosum atro-
phy was absent. On high-resolution T2-weighted im-
aging, vascular contact between the glossopharyngeal
nerve and the right posterior inferior cerebellar artery
(PICA) was observed (Figures 2 and 3). A magnetic res-
onance angiogram of the head revealed the posterior in-
ferior cerebellar artery originating from the right
vertebral artery and that the left vertebral artery was
underdeveloped, along with compression of the right
glossopharyngeal (GP) nerve by the PICA (Figure 4).
A soft diet with hydration using intravenous 5%
dextrose in half amount of normal saline 1000ml
Figure 2 Magnetic resonance imaging scans: high-resolution, T2-weighted, transverse plane. Vascular contact between the
glossopharyngeal nerve (yellow) exiting the retro-olivary fossa (olive green) and right posterior inferior cerebellar artery (PICA).
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Treatment included methylprednisolone 1g intraven-
ously daily for three days, carbamazepine 200mg orally
twice a day, and paracetamol 650mg orally every six
hours as needed.
At the end of the second day our patient reported a
marked improvement in pain with absence of pain at
nighttime and during sleep. Her speech improved and
she requested to advance her diet from soft to mechan-
ical soft.
While on carbamazepine, she reported reasonable
control of her glossopharyngeal pain. She also reported
that once she missed a dose of her medications, the
pain rapidly recurred. The options for surgical interven-
tion such as microvascular decompression versus Gamma
KnifeW treatment were discussed with our patient in
case medical treatment failed; however, she rejectedFigure 3 Magnetic resonance imaging scans: T2-weighted image, sag
inferior cerebellar artery (PICA) arises from the vertebral artery. The upwardany further interventions. Our patient was discharged
on carbamazepine.
Discussion
GPN is a distinctive but rare painful syndrome. The inci-
dence of GPN-like trigeminal neuralgia is higher among
patients with MS than in the general population [2,3].
Trigeminal neuralgia occurs much more commonly in
patients with MS (4000 per 100,000) [4] than in the gen-
eral population (12.6 per 100,000) [3].
Usually the incidence of GPN increases with age and
most often affects persons older than 50 years; however,
in patients with MS, GPN tends to occur at a younger
age [4]. Our patient had longstanding MS; however, she
developed GPN at the age of 56, pointing towards po-
tential secondary causes of GPN. The distribution of the
pain in GPN can be different. It can be otitic (pain inittal plane. Scan shows the vertebrobasilar system. The posterior
buckle almost reaches the caudal pons.
Figure 4 Magnetic resonance angiogram. The posterior inferior cerebellar artery (PICA) originates from the right vertebral artery. The left
vertebral artery is underdeveloped.
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(pain in the side or back wall of the pharynx, posterior
third of the tongue, fauces, tonsil, or soft palate) similar
to our patient. Otitic pain does not often radiate, while
oropharyngeal pain radiates to the ear or adjacent
regions in the majority of cases, as was the case with our
patient. The pain is described as ‘burning’ and less fre-
quently as ‘stabbing’,‘cutting’ or ‘like needles’. Occasion-
ally it manifests as a ‘continuous ache’, a ‘pressure pain’,
‘throbbing’ or ‘sticking’. There can be considerable vari-
ation in the mode of onset and frequency and duration
of attacks. Most often the onset is sudden and spontan-
eous, however, a gradual onset of an increasingly severe
pain also occurs. The attacks tend to occur with a fre-
quency of one to five per year. The attacks usually last
from several weeks to one to two months with pain-free
days during the attack period. The duration of the neur-
algic pain is usually from seconds to minutes (up to 20
minutes). The number of these neuralgic pains in a 24-
hour period commonly averages between five to thirty
(up to one hundred) and they occur during day and
night. The severity of the pain is also extremely variable
(from mild to severe). Mild attacks occur and cause
minor inconvenience. Usually patients are stable be-
tween the attacks, but some of them have mild, episodic
‘sticking sensations’ in the same area as the pain. The
most commonly observed precipitating factor is swal-
lowing (saliva, solid foods and liquids), which was
present in our patient. Chewing and talking have also
been described as triggers, as in our patient. Infrequent
causes are yawning, movements of the head, straining
and mouth movements. Certain foods, independent ofthe act of swallowing, may precipitate an attack (bitter,
spicy, salty), but never sweet [5].
Other non-painful clinical manifestations include sen-
sations of a swollen soft palate, headache, and
hyperesthesia, which may occur for several hours, usu-
ally in a secondary field, after the pain has subsided.
Other less frequent presentations of GPN consist of
burning sensations in the muscles of the neck, diffi-
culty in swallowing liquids and solids, excessive secre-
tion of saliva, bilateral tinnitus, bilateral lacrimation,
flushing and sweating, irritation in the throat and ex-
cessive coughing, dizzy attacks, objective vertigo and
unsteadiness, bradycardia and even cardiac arrest with
syncope [6].
The causes of GPN are diverse and are usually divided
into two groups. Secondary underlying causes such as
neoplasm or inflammatory diseases, such as MS, affect
the glossopharyngeal nerve at different levels of its path
at brainstem structures, cisternal branches, jugular for-
amen, and extracranial divisions. Development of GPN
in MS is quite rare and most cases are attributed to
the underlying demyelinating process. Minagar and
Sheremata [4] reported a cohort of four patients with MS
with GPN with no vascular compressive lesions of the
glossopharyngeal nerve. Patients with GPN and without
an identifiable underlying pathological process are re-
ferred to as having essential or idiopathic GPN. Idio-
pathic GPN according to some authors is caused by
compression of cisternal part of the glossopharyngeal
nerve by intracranial vessels [7]. For this reason micro-
vascular decompression (MVD) is successful in the ma-
jority of the cases but not in all [8]. A three-dimensional
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between blood vessels and neural tissue is not visibly dif-
ferent on the symptomatic and asymptomatic sides, thus
discounting any consistent causal relationship to pain
[9]. In our patient, we demonstrated a definitive contact
between the PICA and glossopharyngeal nerve that could
explain our patient’s symptomatology. Diagnostic investi-
gation for GPN should exclude MS and local compres-
sion, particularly by cancerous lesions, which require
more aggressive treatments. Vascular compression is a
common and potentially treatable cause of GPN but does
not account for all previously designated idiopathic cases.
The proposed mechanisms of irritation of the glosso-
pharyngeal nerve and the resultant painful paroxysms
include hyperexcitability of the glossopharyngeal nerve
and ephaptic conduction; however, none have been fully
explored. Based on current hypotheses, it is suggested
that compression of the glossopharyngeal nerve at the
nerve root entry zone results in demyelination and
ephaptic transmission among the glossopharyngeal
nerve axons; another theory suggests that vascular com-
pression of a nerve induces repetitive activation of pri-
mary afferents in the nerve and leads to hyperactivity
and hyperexcitability in the central neurons; the last im-
plies activation of N-methyl-D-aspartic acid receptors in
the compressed nerve [10]. In patients with MS demye-
linating plaques at the root entry zone could be the po-
tential cause of paroxysmal TN [11]. Most probably
similar root entry zone lesions of the glossopharyngeal
nerve are associated with ephaptic conduction, which
may serve as an alternative explanation of GPN in our
patient with MS.
Medical treatment of GPN with carbamazepine or
gabapentin is effective in the majority of patients. Our
patient responded well to carbamazepine at a moderate
dose. In cases refractory to medical therapy surgical
methods could be applied. Surgical methods include
destruction of petrous ganglion (radiofrequency percu-
taneous rhizothomy, Gamma KnifeW stereotactic radio-
surgery), extracranial (neurotomy) or intracranial
(rhizotomy) resection of glossopharyngeal nerve [12],
separation of the vessel from the nerve (MVD) [13],
destruction of glossopharyngeal nerve ascending fibers
(tractotomy) [14], motor cortex stimulation, thalamic
and other deep brain stimulation, and centrally admi-
nistered opioids. More recently, endoscopy has been
employed as the sole modality in glossopharyngeal
nerve decompression [15].
Conclusions
In summary, patients with MS who present with new-
onset GPN must be thoroughly assessed for the presence
of treatable causes of GPN and it should not be auto-
matically attributed to the presence of demyelinatinglesions that affect the glossopharyngeal nerve. We
strongly recommend vascular imaging studies such as
magnetic resonance angiography of the head and neck
vessels in all patients with MS with GPN in order to
diagnose or exclude vascular compressive lesions of the
glossopharyngeal nerve.
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